BMEA
Biomea Fusion, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.85
−2.59%Next report
Analyst consensus
- Next report date
- Nov 3, 2026
- EPS estimate
- -$0.21
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- -$0.12
- EPS estimate
- -$0.22
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 4
- EPS misses (12Q)
- 7
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- -21.1%
- Revenue beats (12Q)
- —
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $7.00
- PT range
- $4.00 – $10
- Analysts
- 3
3 Buy0 Hold0 Sell
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 6, 2026 | -$0.22 | -$0.12 | Beat 46.30% | — |
| May 11, 2026 | -$0.24 | -$0.17 | Beat 29.17% | — |
| Mar 24, 2026 | -$0.25 | -$0.64 | Miss -156.00% | — |
| Nov 4, 2025 | -$0.26 | -$0.27 | Miss -3.85% | — |
| Mar 31, 2025 | -$1.00 | -$0.81 | Beat 19.00% | $1.2M |
| Jul 31, 2024 | -$1.03 | -$1.03 | In line | — |
| May 2, 2024 | -$1.02 | -$1.09 | Miss -6.86% | — |
| May 2, 2023 | -$0.80 | -$0.98 | Miss -22.50% | — |
| Aug 1, 2022 | -$0.60 | -$0.59 | Beat 1.67% | — |
| May 16, 2022 | -$0.53 | -$0.56 | Miss -5.66% | — |
| Feb 28, 2022 | -$0.45 | -$0.51 | Miss -13.33% | — |
| Nov 3, 2021 | -$0.40 | -$0.43 | Miss -7.50% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 3, 2026